欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/3214/001
药品名称Levosimendan Kalceks
活性成分
    • levosimendan 2.5 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Akciju sabiedrība Kalceks Krustpils Iela 71E 1057 Riga Latvia
参考成员国 - 产品名称Denmark (DK)
互认成员国 - 产品名称
    • Ireland (IE)
    • Estonia (EE)
    • Austria (AT)
    • Hungary (HU)
    • France (FR)
    • Bulgaria (BG)
      Levosimendan Kalceks
    • Spain (ES)
    • Czechia (CZ)
      Levosimendan Kalceks
    • Portugal (PT)
    • Romania (RO)
      Levosimendan Kalceks 2.5 mg/ml concentrat pentru soluţie
    • Italy (IT)
    • Slovakia (SK)
    • Sweden (SE)
    • Slovenia (SI)
    • Norway (NO)
    • Croatia (HR)
    • Finland (FI)
    • Germany (DE)
      Levosimendan Kalceks 2,5 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • Poland (PL)
      Levosimendan Kalceks
    • Belgium (BE)
    • Latvia (LV)
    • Netherlands (NL)
    • Lithuania (LT)
      Levosimendan Kalceks 2,5 mg/ml koncentratas infuziniam tirpalui
许可日期2022/01/24
最近更新日期2024/05/24
药物ATC编码
    • C01CX08 levosimendan
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase